Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Fig. 5

Network evidence map of all-cause mortality. A total of 16 studies reported the all-cause mortality of IPF treated with 11 drugs: 1 of Ambrisentan, 2 of Bosentan,1 of Imatinib, 1 of Macitentan, 1 of N-acetylcysteine, 3 of Nintedanib, 1 of Pamrevlumab, 3 of Pirfenidone, 1 of Sildenafil, 1 of Simtuzumab, 1 of Warfarin

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us